Revascularization versus medical treatments in stable coronary artery disease: predicting the future of novel drug therapies for stable angina

Journal of Cardiovascular Pharmacology
Lamprini Risos, Guy Berkenboom

Abstract

Over the past 2 decades, drug therapy of patients with stable angina pectoris has improved, with a marked impact on the hard clinical outcomes of mortality and myocardial infarction. In contrast, recent trials have not demonstrated beneficial effects of revascularization on mortality. However, in the large trials that compared medical treatment with percutaneous coronary intervention (PCI) or surgery, high-risk patients, such as those with severe 3-vessel disease with or without left ventricular dysfunction, were excluded. In the COURAGE and FAME 2 trials, the only difference between the PCI and medical therapy groups was a higher rate of revascularization in the latter. Similar findings were made in studies comparing medical treatment with coronary surgery. New pharmacological approaches are being developed to further delay the progression of atherosclerosis. These include new lipid-lowering drugs acting in concert with statins (cholesteryl ester transfer protein inhibitors, proprotein convertase subtilisin/kexin type 9 inhibitors), aldosterone antagonists, colchicine, methotrexate, and interleukin-1 inhibitors. In conclusion, from the available data, PCI and coronary surgery have not been shown to improve hard end points and ...Continue Reading

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel
Dec 4, 2002·Circulation·R K KharbandaR MacAllister
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Bernard R ChaitmanUNKNOWN Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators
Feb 1, 2005·Journal of the American College of Cardiology·Emile FerrariBaudouy Marcel
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·James K Liao, Ulrich Laufs
Mar 7, 2006·Cardiovascular Research·Robert A Kloner, Shereif H Rezkalla
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
Nov 6, 2009·The New England Journal of Medicine·A Laurie ShroyerUNKNOWN Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group
Jun 8, 2010·European Heart Journal·William Wijns, Philippe H Kolh
Dec 4, 2010·The American Journal of Cardiology·C Venkata S Ram
Apr 6, 2011·The New England Journal of Medicine·Eric J VelazquezUNKNOWN STICH Investigators
Apr 6, 2011·The New England Journal of Medicine·Robert O BonowUNKNOWN STICH Trial Investigators
Jul 7, 2011·JAMA : the Journal of the American Medical Association·Paul S ChanJohn A Spertus
Nov 17, 2011·The New England Journal of Medicine·William E BodenWilliam Weintraub
Mar 23, 2012·The New England Journal of Medicine·Evan A SteinGary D Swergold
Aug 29, 2012·The New England Journal of Medicine·William E Boden
Aug 29, 2012·The New England Journal of Medicine·Bernard De BruyneUNKNOWN FAME 2 Trial Investigators
Sep 8, 2012·Journal of the American College of Cardiology·Mario MarzilliWilliam S Weintraub
Sep 12, 2012·Current Medicinal Chemistry·C StefanuttiS Di Giacomo
Nov 7, 2012·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN dal-OUTCOMES Investigators
Dec 26, 2012·Journal of the American College of Cardiology·Stefan M NidorfPeter L Thompson
Mar 13, 2013·The New England Journal of Medicine·Anno DiegelerUNKNOWN GOPCABE Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Circulation. Cardiovascular Quality and Outcomes
William S WeintraubDepartment of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators
Circulation. Cardiovascular Quality and Outcomes
Bina AhmedNorthern New England Cardiovascular Disease Study
© 2021 Meta ULC. All rights reserved